AACR-Waun Ki Hong Award for Outstanding Achievement in Cancer Research Recipient
This award recognizes a worthy cancer researcher who has conducted highly meritorious laboratory, translational, or clinical cancer anywhere in the world at a relatively early state in his or her career.
Inaugural Award Recipient
Roger S. Lo, MD, PhD
Professor, Medicine/Dermatology and Molecular and Medical Pharmacology
Member, Jonsson Comprehensive Cancer Center
David Geffen School of Medicine a UCLA
Los Angeles, California
Dr. Lo delivered his award lecture titled “Therapeutic Resistance in Melanoma" at the AACR Annual Meeting 2017 in Washington, D.C. The award presentation and lecture were held Monday, April 3, 2017, at the Washington Convention Center.
The AACR established this Award in recognition of Dr. Hong's extraordinary contributions to cancer research, cancer care, and cancer prevention during his brilliant career as a physician-scientist. This award recognizes a worthy cancer researcher who has conducted highly meritorious laboratory, translational, or clinical cancer research anywhere in the world at a relatively early stage in his/her career. It will honor the outstanding research of a young investigator who has not yet reached 46 years of age at the time of the award presentation.
Roger S. Lo, MD, PhD, is recognized for pioneering research which identified the molecular underpinnings of metastatic melanoma and its response to therapy. His work has provided the major scientific rationale toward the use of inhibitors of BRAF and MEK in combination to effectively treat melanoma – a therapeutic approach that is now globally considered the standard of care. Studies from his group have provided rationale to additional clinical trials and foundational knowledge on the roles of tumor heterogeneity, non-genomic processes and the tumor microenvironment in determining clinical responses to targeted and immunotherapies. Dr. Lo’s achievements reflect his group’s focus on generating the most clinically relevant biologic insights into advanced melanoma as an evolutionarily dynamic cancer.
Dr. Lo is Professor of Medicine/Dermatology and Molecular and Medical Pharmacology at the David Geffen School of Medicine at the University of California, Los Angeles and the Jonsson Comprehensive Cancer Center. He is the Director of the Melanoma Clinic in Dermatology. He earned his Bachelor of Science degree in Biology with Honors and Distinction in 1994 from Stanford University and his MD and PhD degrees from the Tri-institutional (Weill Cornell, Memorial Sloan-Kettering, and Rockefeller) MD-PhD Program in 2002.
Dr. Lo has received multiple honors and awards, including a Career Award in Medical Science from the Burroughs Wellcome Fund, Translational Scholar Awards from the V Foundation and the Sidney Kimmel Foundation, awards from the Melanoma Research Alliance, and the Innovative Research Grant from Stand Up To Cancer. He was elected to the American Society for Clinical Investigation in 2012 and in 2013 received the 33rd Annual Award for Outstanding Achievement in Cancer Research from the American Association for Cancer Research.